Here we demonstrate that by selectively targeting EMMPRIN, a multifunctional protein that is primarily involved in angiogenesis, we reduced angiogenesis and ameliorated clinical manifestations of the DSS-induced colitis model, including weight loss and disease severity, pointing to the central role that angiogenesis plays in this model. Here, BSG is linked to colitis.